tiprankstipranks
Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market
Holding SMMT?
Track your performance easily

Summit Therapeutics (SMMT) Dividend Date & History

1,218 Followers
Summit Therapeutics (SMMT) has no upcoming dividends

Other Large Cap Stocks Paying Dividends

Name
Dividend Yield
Smart Score
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Follow
MO
Altria Group
$3.998 (7.48%)
$88.22B
8.88
29.78%
4 Buy
3 Hold
2 Sell
Hold
T
AT&T
$1.108 (4.6%)
$175.08B
16.36
41.45%
17 Buy
4 Hold
0 Sell
Strong Buy
XRX
Xerox
$1 (10.3%)
$1.20B
-0.85
-53.34%
0 Buy
1 Hold
2 Sell
Moderate Sell
IBM
International Business Machines
$6.666 (2.97%)
$207.86B
32.72
19.77%
4 Buy
5 Hold
1 Sell
Moderate Buy
CVX
Chevron
$6.52 (4.15%)
$279.72B
17.19
4.78%
16 Buy
3 Hold
0 Sell
Strong Buy
EOG
EOG Resources
$3.705 (3.9%)
$74.14B
10.49
13.30%
11 Buy
12 Hold
0 Sell
Moderate Buy
ET
Energy Transfer
$1.272 (6.06%)
$72.07B
15.49
36.34%
9 Buy
1 Hold
0 Sell
Strong Buy
HESM
Hess Midstream Partners
$2.636 (6.56%)
$9.00B
17.30
20.03%
1 Buy
1 Hold
0 Sell
Moderate Buy
ARCC
Ares Capital
$1.916 (8.24%)
$15.14B
9.03
14.72%
9 Buy
2 Hold
0 Sell
Strong Buy

FAQ

Does Summit Therapeutics pay dividends?
No, Summit Therapeutics (SMMT) has not paid a dividend within the past 12 months.
    How much is Summit Therapeutics's dividend?
    Summit Therapeutics (SMMT) does not pay a dividend
    When is Summit Therapeutics ex-dividend date?
    Summit Therapeutics (SMMT) does not pay a dividend.
    When is Summit Therapeutics dividend payment date?
    Summit Therapeutics (SMMT) does not pay a dividend.
    Does Summit Therapeutics have sufficient earnings to cover their dividend?
    The Summit Therapeutics has paid a dividend in the last year and may provide dividends in the near future.
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis